Resources
Advanced Search
Start Free Trial
Talk With Sales
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Editact
CB Rank
422965
Heat Score
42
Save
Actions
Editact specializes in the development of novel gene treatments for Alzheimer's disease.
Founded
obfuscated
obfuscation
Private
Seed
Hong Kong
,
Hong Kong Island
,
Hong Kong
1-10
Biotechnology
Health Care
Therapeutics
Editact
Section: Overview
Actions